PCN136 ECONOMIC VIABILITY OF CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR ADULTS WITH ADVANCED LEUKEMIA: EVIDENCE FROM AN EARLY ECONOMIC MODELLING

Autor:	N. Kekre, T. Hawrysh, Dean Fergusson, Kednapa Thavorn, Douglas Coyle, S. van Katwyk, H. Atkins, Manoj M. Lalu
Rok vydání:	2019
Předmět:	Leukemia Economic viability business.industry Health Policy Public Health Environmental and Occupational Health Cancer research Medicine Chimeric Antigen Receptor T-Cell Therapy business medicine.disease
Zdroj:	Value in Health. 22:S461-S462
ISSN:	1098-3015
DOI:	10.1016/j.jval.2019.09.332
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b2d02bfc6e3c98dd2b97d00868b31ee2 https://doi.org/10.1016/j.jval.2019.09.332 Zobrazit plný text záznamu Full Text from ScienceDirect